Professional Supplier of Nano-Targeted Drug Scientific Research Products

cart
Our Products
  • APIs & Intermediates
  • Biotinylation Reagents
  • Phospholipids
  • Lipid PEGs
  • Functional PEGs
  • Polyester PEGs
  • Polyamino Acids
  • Polymers & Copolymers
  • Gold Nanoparticles
  • Iron Oxide Nanoparticles
  • Silica Particles
  • Quantum Dots
  • Upconverting Nanoparticles
  • Inorganic Nanomaterials
  • Fluorescent Dyes
  • Protein & Enzyme Conjugates
  • Polysaccharides
  • PEG Linkers with Small Molecular
  • Crosslinkers
  • Click Chemistry
  • ADC Linkers
  • MOF Materials
  • Liposomes
  • Hydrogels
  • Microspheres
  • AIE Materials
  • New Release
APIs & Intermediates View More
Biotinylation Reagents View More
Phospholipids View More
Lipid PEGs View More
Functional PEGs View More
Polyester PEGs View More
Polyamino Acids View More
Polymers & Copolymers View More
Gold Nanoparticles View More
Iron Oxide Nanoparticles View More
Silica Particles View More
Quantum Dots View More
Upconverting Nanoparticles View More
Inorganic Nanomaterials View More
Fluorescent Dyes View More
Protein & Enzyme Conjugates View More
Polysaccharides View More
PEG Linkers with Small Molecular View More
Crosslinkers View More
Click Chemistry View More
ADC Linkers View More
MOF Materials View More
Liposomes View More
Hydrogels View More
Microspheres View More
AIE Materials View More
New Release View More
Click Chemistry

R848-N3+CA4 NP

Catalog: TASK-20-5001449   CAS NO.: N/A
Delivery Fill in your shipping address to check the estimated shipping fee of your order

Select Shipping Address

$0.00 delivery Normal Delivery(7Days) Details Cyprum itidem insulam procul a continenti

$0.00 delivery Express Delivery Details Cyprum itidem insulam procul a continenti

  • High Quality Products
  • Fast and Safe Delivery

Description

R848-N3+CA4 NP represents an advanced nanoparticle-based drug delivery system designed for cancer therapy. This formulation incorporates two key components: R848-N3, an azide-masked prodrug form of the immune-modulating agent R848 (Resiquimod), and CA4 (Combretastatin A-4), a potent microtubule-disrupting agent with vascular-targeting properties. Encapsulating these compounds in nanoparticles (NPs) allows for their co-delivery to the tumor microenvironment, where they can exert synergistic therapeutic effects. This approach leverages the enhanced permeability and retention (EPR) effect to accumulate the nanoparticles specifically in tumor tissues, improving the therapeutic index and minimizing systemic toxicity.

Specifications

CAS No.N/A
FormulaN/A
Molecular WeightN/A
Purity98%
Ship Within1 week
Storage Temp.N/A
Shipping4-25℃ for up to 3 weeks
Welcome to Taskcm

This email already exists.

Username already exists.

Please confirm the password is the same.

or